APA (7th ed.) Citation

Kastritis, E., Palladini, G., Minnema, M. C., Wechalekar, A. D., Jaccard, A., Lee, H. C., . . . Hungria, V. (2021). Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. New England Journal of Medicine, 385(1), 46. https://doi.org/10.1056/NEJMoa2028631

Chicago Style (17th ed.) Citation

Kastritis, E., et al. "Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis." New England Journal of Medicine 385, no. 1 (2021): 46. https://doi.org/10.1056/NEJMoa2028631.

MLA (9th ed.) Citation

Kastritis, E., et al. "Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis." New England Journal of Medicine, vol. 385, no. 1, 2021, p. 46, https://doi.org/10.1056/NEJMoa2028631.